Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR)

157 filings reported holding LRMR - Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2025.
Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 85.5M shares of 85.6M outstanding shares and own 99.84% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (30.6M shares), RA CAPITAL MANAGEMENT, L.P. (6.05M shares), Blue Owl Capital Holdings LP (5.85M shares), MILLENNIUM MANAGEMENT LLC (4.9M shares), Opaleye Management Inc. (3.72M shares), BlackRock, Inc. (3.34M shares), RTW INVESTMENTS, LP (3.13M shares), VANGUARD GROUP INC (3.09M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.9M shares), and Alyeska Investment Group, L.P. (1.89M shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.